Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,500
Closed -$388K 111
2022
Q4
$388K Sell
3,500
-37,300
-91% -$3.81M 0.04% 61
2022
Q3
$3.51M Buy
40,800
+13,500
+49% +$1.21M 0.29% 59
2022
Q2
$2.49M Sell
27,300
-55,000
-67% -$4.88M 0.18% 76
2022
Q1
$6.75M Buy
+82,300
New +$6.49M 0.26% 78
2021
Q4
Sell
-30,700
Closed -$2.31M 202
2021
Q3
$2.31M Buy
+30,700
New +$2.33M 0.15% 104
2021
Q2
Sell
-4,402
Closed -$324K 287
2021
Q1
$324K Buy
4,402
+3,983
+951% +$294K 0.03% 89
2020
Q4
$32K Buy
+419
New +$32K ﹤0.01% 134

Other funds holding MRK

QVR's MRK Position: Q2 2026 in Review

QVR sold out of Merck (MRK) in Q2 2026, closing a stake of 13,715 shares — an estimated $1.65M sold.

QVR first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $2.49M in Q4 2025. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • QVR reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • QVR sold 13,715 Merck shares in Q2 2026, an estimated $1.65M.
  • QVR first reported a position in Merck in Q4 2020 and held it in 6 quarters.
  • QVR's Merck position peaked at $2.49M in Q4 2025.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.